应用DNA科学GAAP每股收益为-0.32美元，落后0.02美元，收入为81万美元，落后0.09万美元

2024-12-18 05:35

Applied DNA Sciences press release (NASDAQ:APDN): Q4 GAAP EPS of -$0.32 beats by $0.02.
Revenue of $0.81M (+3.8% Y/Y) misses by $0.09M.
Adjusted EBITDA for the fourth quarter of fiscal 2024 was a negative $3.2 million compared with a negative $3.5 million in the prior year period.
Cash and cash equivalents on September 30, 2024, totaled $6.4 million. On October 31, 2024, the Company completed a registered direct offering and received net proceeds of approximately $5.8 million after deducting placement agent fees and other estimated offering costs payable by the Company. As a result of this offering, cash and cash equivalents as of November 3, 2024, were approximately $10.1 million.
Shares -25.65%.

More on Applied DNA Sciences